Pioglitazone 30mg

DRUG4 trials

Sponsors

University at Buffalo, Tanta University, University of Basrah, Emory University

Conditions

InflammationNon Alcoholic SteatohepatitisPulmonary HypertensionPulmonary Hypertension Due to Lung DiseasesType2diabetes

Phase 2

Bioenergetic Effect of Pioglitazone in CLD-PH

RecruitingNCT06336798

Emory UniversityPulmonary Hypertension, Pulmonary Hypertension Due to Lung Diseases

Start: 2024-12-17End: 2028-02-29Target: 20Updated: 2025-07-03

Phase 3

Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis

Tanta UniversityNon Alcoholic Steatohepatitis

Start: 2022-11-30End: 2024-11-30Target: 56Updated: 2022-11-04

Effect of Short-term Basal Insulin Initiation in Newly Diagnosed Type 2 Diabetes on 1-year Glycemic Control

CompletedNCT06107153

University of BasrahType2diabetes

Start: 2023-11-01End: 2024-11-01Updated: 2025-03-30

Phase 4

Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study

CompletedNCT01161394

University at BuffaloInflammation

End: 2003-10-31Target: 24Updated: 2022-01-27